Abstract P1-12-05: Aromatase inhibitor induced musculoskeletal syndrome (AIMSS) in Australian women with early breast cancer: An Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) survey of members of the Breast Cancer Network Australia (BCNA)
Conclusion: AIMSS is a significant issue for Australian women and is an important reason for AI discontinuation. Women use a number of interventions to manage AIMSS, however their efficacy appears limited. Effective AIMSS interventions are needed, to improve quality of life and reduce AI discontinuation.
Citation Format: Janine M Lombard, Nicholas Zdenkowski, Kathy Wells, Nicca Grant, Linda Reaby, John F Forbes, Jacquie Chirgwin. Aromatase inhibitor induced musculoskeletal syndrome (AIMSS) in Australian women with early breast cancer: An Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) survey of members of the Breast Cancer Network Australia (BCNA) [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr P1-12-05.
Source: Cancer Research - Category: Cancer & Oncology Authors: Lombard, J. M., Zdenkowski, N., Wells, K., Grant, N., Reaby, L., Forbes, J. F., Chirgwin, J. Tags: Poster Session Abstracts Source Type: research
More News: Acupuncture | Alternative and Complementary Therapies | Back Pain | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Complementary Medicine | Glucosamine | Grants | Krill Oil | Men | Menopause | Morphine | Pain | Vitamins | Women